Follow us:

REPRODIVAC - Next-generation vaccines and diagnostics to prevent livestock reproductive diseases of worldwide impact

News

Training and collaboration between ENEA and TPI

Simon Graham and colleagues from The Pirbright Institute recently hosted Marco Costantini, a PhD student at ENEA Biotechnology Laboratory.

They worked together to characterize the activity of a plant produced glycoengineered monoclonal antibody.  This antibody will be used  in an in vivo study in pigs to assay pharmacokinetics and safety profile.

people in description
From left to right: Rory De Brito, Simon Graham, Jack Hayes, Marco Costantini.

REPRODIVAC has received funding from the European Union’s Horizon Europe research and innovation programme under Grant Agreement No. 101060813. Views and opinions expressed are however those of the author(s) only and do not necessarily reflect those of the European Union or other granting authorities. Neither the European Union nor the other granting authorities can be held responsible for them.

REPRODIVAC has received funding from the European Union’s Horizon Europe research and innovation programme under Grant Agreement No. 101060813. Views and opinions expressed are however those of the author(s) only and do not necessarily reflect those of the European Union or other granting authorities. Neither the European Union nor the other granting authorities can be held responsible for them.
Feedback